Activity, rehabilitation and muscle preservation, explored through three full articles. Keep the distinction between a trial, an association and a review in view.
OCTOBER 29 ONLINE UPDATE · SOURCE EDITION OCTOBER 27
Exercise and thinking skills in mild cognitive impairment
A review of 38 studies suggests benefits on cognitive tests, with low-to-moderate certainty. It does not establish dementia prevention.
What the researchers studied
The review combined 38 randomized studies in adults aged 60 or older with mild cognitive impairment. Comparators included usual care, low-intensity activity or another exercise approach. The researchers examined working memory, cognitive flexibility and inhibitory control: skills involved in holding information in mind, switching tasks and resisting automatic responses. People with dementia were excluded.
What the model suggested
The authors used a Bayesian network meta-analysis to compare exercise approaches and model dose-response patterns across studies. Gains tended to rise and then flatten. Moderate doses were associated with more reliable improvements; higher modeled ranges showed plateaus or modest declines. Exercise combined with cognitive training was most consistent for working memory, while walking and broader physical training showed more stable effects on flexibility and inhibitory control.
Why this is not a universal exercise target
The dose ranges came from a model combining different studies, not one trial that randomly assigned everyone to several directly comparable weekly doses. They should not be read as a personal prescription or evidence that more exercise generally harms the brain. The certainty ranged from low to moderate. The accessible abstract does not provide pooled effect sizes, total participant numbers, follow-up duration across studies or enough information to judge the practical size and durability of the benefits.
Thinking-test gains are not dementia prevention
These findings concern performance on executive-function measures in people who already had mild cognitive impairment. They do not establish prevention of dementia, independence in everyday life or longer lifespan. Those outcomes need their own evidence. The authors call for trials that directly compare multiple exercise doses.
How this fits the collection
The earlier articles in this booklet discuss activity patterns, frailty, cardiac rehabilitation and muscle preservation. This new article adds cognition as a separate outcome. Together they encourage attention to what a program actually measures: strength, walking capacity, a cognitive score and a clinical diagnosis answer different questions.
Sources and review limits
Adapted from The Arising, October 27, 2026, story 10 of 21, pages 26-27: Moderate Exercise Doses Linked to Best Executive Function Gains in MCI. Primary record: PMID 42921532; DOI 10.7717/peerj.21805, PeerJ 14:e21805 (2026; exact publication day not verified). The primary abstract was checked October 29. Full text and supplements were inaccessible in this check; harms, funding and conflicts were not established. No individualized exercise advice. Earlier articles retain their original review dates.
31 OCTOBER 2026 · STRENGTH COLLECTION UPDATE · SEPTEMBER REVIEW
Original conceptual illustration for this article; not a scientific diagram.
CoQ10: from energy to evidence
What would make a supplement worth taking: a persuasive explanation of cellular energy, or a measurable difference in what we can do? The Arising’s October 31 full article asked that question of CoQ10. The review it covered was published in September; this is a fresh reading of existing research, not a new trial announced today.
The question the review tested
Researchers gathered 33 randomized trials involving 3,317 participants; 21 contributed to quantitative pooling. Eligible studies had a mean or median age of at least 40, which does not mean every participant was over 40. Populations ranged from healthy adults to people with chronic disease. CoQ10 was compared with placebo, no supplementation or an otherwise equivalent control. Treatment periods ranged from 17 days to 60 months, with different formulations and doses.
The number behind the headline
Only five studies, involving 172 participants, contributed to the primary pooled estimate of relative peak oxygen uptake. The average difference favored CoQ10 by 0.73 mL/kg/min, but the 95% confidence interval ran from -0.07 to 1.54. That interval includes no benefit. The authors rated this evidence low certainty. The total of 3,317 participants should not be mistaken for the sample behind this particular result.
Uncertain does not mean proven useless
The primary estimates for walking capacity, strength, chair-rise performance and muscle quantity also remained uncertain. Evidence across key outcomes was low or very low certainty. An expanded oxygen-uptake analysis that used additional statistical assumptions favored CoQ10, but it did not replace the primary analysis or establish a clinically meaningful benefit. The review cannot settle every disease-specific use or identify a reliable responder subgroup.
A mechanism needs a functional test
CoQ10 has a role in mitochondrial energy production. That makes it a reasonable research question; it does not demonstrate that taking more improves everyday function. The authors found frequent risk-of-bias concerns and sparse evidence for individual outcomes. Frail older adults with sarcopenia were not specifically represented as a target population. No lifespan-extension claim follows from these findings.
The next useful question
Better studies should specify which people might benefit, measure meaningful physical outcomes and report harms alongside efficacy. This review is not a comprehensive safety assessment, and we did not independently audit every underlying trial or supplement. It provides no basis here for personal instructions to start or stop CoQ10. In our strength collection, it sits beside articles on activity, rehabilitation, muscle preservation and cognition: different outcomes, each requiring its own evidence.
Sources and review limits
Adapted from The Arising, October 31, 2026, feature 05, pages 15–17: “CoQ10 Not Shown to Improve Muscle or Fitness in Older Adults.” Source PDF FILE_9321.pdf. Primary source: Liu et al., Antioxidants 15(10):1219; DOI 10.3390/antiox15101219; PMID 42939793. PubMed dates publication September 22, 2026; the publisher’s version record also records September 22. This October 31 review checked the PubMed abstract and PMC main text. Supplements and individual trials were not independently reanalysed. Funding: Fundamental Research Funds for the Central Universities (2026KYPT05 and 2026KYPT06); authors declare no conflicts. Underlying-trial funding was not independently audited. Claim IDs AR-20261031-COQ-01–04. Earlier booklet articles retain their original review dates.
The November 2 Arising discussion asks what a longevity program should help people do, connecting exercise and nutrition to the question of physical function. It draws on the full article “The most useful strength program may train several abilities at once” in our November 2 Health Intelligence edition. The primary review appeared online on May 28, 2026; its November journal issue is not a new result announced today.
The linked posts preserve the limits of an abstract-level review. This is connected reading, not a specific training or supplement prescription, and does not revise the dated booklet PDF.
